Brainomix Launches Award-Winning Next Generation Stroke AI Platform with Novel Net Water Uptake Technology at the International Stroke Conference (ISC)

Why It Matters

By delivering automated, quantitative NWU insights, the platform enhances decision‑making for severe stroke cases, potentially expanding access to life‑saving therapies and improving outcomes across health systems.

Key Takeaways

• Red Dot Design Award recognizes platform’s usability and innovation
• First AI tool to quantify net water uptake on CT
• NWU metric improves stroke treatment decisions and prognostication
• Cost-effectiveness study predicts higher thrombolysis rates
• Five ISC abstracts showcase expanded clinical evidence

Pulse Analysis

Artificial intelligence is reshaping acute stroke care, but most tools focus on detecting large vessel occlusions or estimating core volume. Brainomix’s new net water uptake (NWU) feature pushes the frontier by quantifying tissue edema directly from standard non‑contrast CT, a biomarker increasingly linked to infarct progression and therapeutic windows. This regulatory‑cleared, fully automated metric equips clinicians with granular, patient‑specific data without additional imaging, streamlining triage and potentially widening eligibility for reperfusion therapies.

Beyond its analytical capabilities, the platform’s Red Dot Design Award underscores a growing emphasis on clinician‑friendly interfaces. The award, traditionally reserved for consumer electronics giants, signals that Brainomix has prioritized intuitive navigation, rapid DICOM loading, and seamless integration into existing radiology workflows. Such usability gains reduce training overhead, accelerate adoption in community hospitals, and support consistent, high‑quality imaging interpretation across diverse care settings.

The clinical narrative is reinforced by robust research presented at ISC, where five abstracts—including three Paul Dudley White International Scholar Award winners—highlight cost‑effectiveness, collateral dynamics, and improved detection of stroke mimics. Early economic modeling predicts that widespread adoption could increase thrombolysis and thrombectomy rates, delivering better functional outcomes and measurable monetary savings. For health systems grappling with stroke burden, Brainomix’s next‑gen platform offers a compelling blend of cutting‑edge AI insight, design excellence, and evidence‑driven value proposition.